These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30638860)

  • 21. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
    Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A
    PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.
    Urakawa H; Nishida Y; Naruse T; Nakashima H; Ishiguro N
    Clin Orthop Relat Res; 2009 Nov; 467(11):2932-8. PubMed ID: 19326179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
    Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A
    BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
    Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
    Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis.
    Zhu H; Cai H; Tang M; Tang J
    Clin Transl Oncol; 2014 Aug; 16(8):732-8. PubMed ID: 24338507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of long non-coding RNA EWSAT1 as a novel prognostic biomarker in osteosarcoma.
    Zhang GY; Zhang JF; Hu XM; Luo ZP; Ma YZ
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5337-5341. PubMed ID: 29243774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
    Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
    Int J Clin Exp Pathol; 2015; 8(8):9314-9. PubMed ID: 26464682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience.
    Berlanga P; Cañete A; Salom M; Montalar J; Guasp M; Marco A; Castel V
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):176-81. PubMed ID: 26925713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and prognostic relevance of centromere protein A in primary osteosarcoma.
    Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH
    Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
    Li F; Cao L; Hang D; Wang F; Wang Q
    Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.
    Colding-Rasmussen T; Thorn AP; Horstmann P; Rechnitzer C; Hjalgrim LL; Krarup-Hansen A; Petersen MM
    Acta Oncol; 2018 Mar; 57(3):420-425. PubMed ID: 28741397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
    Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
    Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of pre-treatment Naples prognostic score (NPS) in patients with osteosarcoma.
    Yang Q; Chen T; Yao Z; Zhang X
    World J Surg Oncol; 2020 Jan; 18(1):24. PubMed ID: 32000789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LDOC1 regulates Wnt5a expression and osteosarcoma cell metastasis and is correlated with the survival of osteosarcoma patients.
    Yong BC; Lu JC; Xie XB; Su Q; Tan PX; Tang QL; Wang J; Huang G; Han J; Xu HW; Shen JN
    Tumour Biol; 2017 Feb; 39(2):1010428317691188. PubMed ID: 28240050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma.
    Sun K; Gong C; Peng H; Fang H; Zhou J; Li J; Chen S; Zheng H
    Mol Med Rep; 2017 Nov; 16(5):6953-6957. PubMed ID: 28901496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma.
    Li Z; Xiao J; Hu K; Wang G; Li M; Zhang J; Cheng G
    Int J Mol Sci; 2015 Jan; 16(2):2294-306. PubMed ID: 25622249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome.
    Arlt MJ; Kuzmanov A; Snedeker JG; Fuchs B; Silvan U; Sabile AA
    BMC Cancer; 2019 Jan; 19(1):83. PubMed ID: 30654764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COPS3 amplification and clinical outcome in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
    Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of hypoxia-inducible factor 1 and VEGF-A in osteosarcoma.
    Zhao H; Wu Y; Chen Y; Liu H
    Int J Clin Oncol; 2015 Dec; 20(6):1233-43. PubMed ID: 26077139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.